EcoDrugPlus

Ensembl ID : ENSHHUG00000008246
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSHHUG00000014360
Gene Symbol: -
Cross references: -
122 Possible Orthologues:

Ensembl ID : ENSHHUG00000007793
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSHHUG00000014618
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSHHUG00000036020
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSHHUG00000036003
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSHHUG00000008293
Gene Symbol: TP53
1 Cross references
160 Possible Orthologues:

Ensembl ID : ENSHHUG00000016950
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSHHUG00000034524
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSHHUG00000034442
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSHHUG00000017109
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSHHUG00000008136
Gene Symbol: -
Cross references: -
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).